XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Note 12 - Loss Per Share (EPS)
3 Months Ended
Mar. 31, 2023
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 12. LOSS PER SHARE (EPS)

 

We calculate basic EPS under the two-class method under which all earnings (distributed and undistributed) are allocated to each class of common stock and participating securities based on their respective rights to receive dividends. Our outstanding convertible preferred stock are considered participating securities as the holders may participate in undistributed earnings with holders of common shares and are not obligated to share in our net losses.

 

We calculate diluted EPS by dividing the net income attributable to RiceBran Technologies common shareholders by the weighted average number of common shares outstanding during the period increased by the number of additional common shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive. We calculate the dilutive effects of outstanding options, warrants and nonvested restricted stock units that vest solely on the basis of a service condition using the treasury stock method. We calculate the dilutive effects of outstanding preferred stock using the if-converted method.

 

Reconciliations of the numerators and denominators in the EPS computations follow.

 

   

Three Months Ended March 31,

 
   

2023

   

2022

 

NUMERATOR (in thousands):

               

Basic and diluted - net loss

  $ (2,028 )   $ (1,516 )
                 

DENOMINATOR:

               

Weighted average number of shares of shares of common stock outstanding

    6,337,031       5,166,491  

Weighted average number of shares of common stock underlying vested restricted stock units

    230,947       86,505  

Basic and diluted EPS - weighted average number of shares outstanding

    6,567,978       5,252,996  

 

No effects of potentially dilutive securities outstanding were included in the calculation of diluted EPS for the three months ended March 31, 2023 and 2022, because to do so would be antidilutive as a result of our net loss. Potentially dilutive securities outstanding at March 31, 2023, included our outstanding convertible preferred stock, options, warrants and nonvested restricted stock units.